查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1258154

個性化醫療副產品（個性化醫療診斷、個性化醫療、個性化醫療、個性化營養/健康）全球市場規模的研究和預測，按地區分析，2022-2029

Global Personalized Medicine Market Size study & Forecast, by Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球個性化醫療市場價值約為 5143.3 億美元，預計在 2022-2029 年預測期內將以超過 6.95% 的健康增長率增長。我來了。

個性化醫療，也稱為精準醫療，將人分成不同的組，並根據患者的預期反應和疾病風險為每個患者量身定制醫療決策、治療、實踐和/或產品。它適用於 這個市場在很大程度上是由對新藥開發的需求不斷增長、癌症患者和其他疾病數量的增加所推動的。 此外，越來越多的臨床試驗推動了 2022-2029 年預測期內的市場增長。 此外，主要市場參與者的參與度增加也為這一時期的市場帶來了有利可圖的增長機會。

此外，預計罕見病的流行將加速市場的擴張。 由於我們對人類基因組特徵的理解和關聯的進步，許多個性化醫療和治療活動的發展成為可能。 例如，2022 年 9 月在加州大學爾灣分校進行的一項研究揭示了一種通過應用高度個性化和精確的基因組編輯來治療遺傳性視網膜疾病 (IRD) 的獨特方法。 與此同時，FDA 批准的伴隨診斷的數量也在增加。 例如，2020年10月，羅氏獲得美國FDA批准擴大使用cobas EGFR Mutation Test治療非小細胞肺癌。 然而，個性化醫療的高成本阻礙了整個 2022-2029 年預測期內的市場增長。

全球個性化醫療市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和拉丁美洲其他地區。 2021年，北美將佔據最大份額。 這導致了大型製藥公司和研究機構的資助。 各種疾病現在最好用個性化藥物治療，因此針對每種情況的藥物發現和研究現在都包括個性化藥物。 用於診斷的個性化醫療正在該地區取得進展。 亞太地區對個性化診斷和新療法的需求正在增長，以應對日益流行的疾病，預計在預測期內增長最快。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品供應的深入分析。 .

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 個性化醫療市場，按地區劃分，2019-2029 年
    • 個性化醫療市場，副產品，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球個性化醫療市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章全球個性化醫療市場動態

  • 個性化醫療市場影響分析（2019-2029 年）
    • 市場驅動力
      • 罕見病患病率
      • 越來越多的臨床試驗
      • 對新藥發現的需求不斷增長
    • 市場挑戰
      • 個性化醫療的高成本
    • 市場機會
      • 主要市場參與者的主動性不斷提高

第四章全球個性化醫療市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球個性化醫療市場：按產品分類

  • 市場概況
  • 全球個性化醫療市場：按產品分類的性能潛力分析
  • 2019-2029 年全球個性化醫療市場按產品估算和預測
  • 個性化醫療市場、細分市場分析
    • 個性化醫療診斷
    • 個性化醫療
    • 個性化醫療
    • 個性化營養和健康

第 7 章。全球個性化醫療市場：區域分析

  • 個性化醫療市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按產品估算和預測
    • 加拿大
  • 歐洲個性化醫療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太個性化醫療市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲個性化醫療市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 8 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 通用電氣醫療
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Illumina, Inc.
    • ASURAGEN, INC.
    • Abbott
    • Dako A/S
    • Exact Sciences Corporation
    • Danaher Corporation（Cepheid, Inc.）
    • Decode Genetics, Inc.
    • QIAGEN
    • Exagen Inc.

第九章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Personalized Medicine Market is valued approximately USD 514.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.95% over the forecast period 2022-2029. Personalised medicine, is also known as precision medicine, it divides people into distinct groups and then tailors medical decisions, therapies, practises, and/or products to each patient depending on that patient's expected response or illness risk. The market is majorly driven by rising demand for novel drug discovery, rising number of cancer cases and other diseases. Along with this, growing number of clinical trials is driving the growth for the market over the forecast period 2022-2029. Moreover, rising initiatives by key market players is creating lucrative growth opportunity for the market over the period.

It is also projected that the rising prevalence of rare diseases will accelerate market expansion. The development of numerous individualized medical treatments and therapeutic activities has been made possible by advances in our understanding and correlation of the properties of the human genome. For instance, a research study conducted at the University of California, Irvine in September 2022 offered a unique method for treating inherited retinal diseases (IRDs) by applying precise genome editing that is highly tailored to the needs of an individual. Along with this, there are an increasing number of companion diagnostics that have received FDA approval. For example, Roche received U.S. FDA clearance in October 2020 to expand the use of the Cobas EGFR Mutation Test for the treatment of non-small cell lung cancer. However, the high cost of Personalized Medicine stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Personalized Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2021, North America had the largest share. This is linked to funding from large pharmaceutical companies and research organisations. All types of ailments are now best treated with personalised medicine, which is why drug discovery and research into any condition now include it. In the region, personalised medicine is advancing for diagnostic purposes. Due to rising demand for personalised diagnostics and novel treatment medications to combat the region's rising disease prevalence, Asia Pacific is anticipated to have the fastest expanding segment over the course of the projection year.

Major market players included in this report are:

  • GE Healthcare
  • Illumina, Inc.
  • ASURAGEN, INC.
  • Abbott
  • Dako A/S
  • Exact Sciences Corporation
  • Danaher Corporation (Cepheid, Inc.)
  • Decode Genetics, Inc.
  • QIAGEN
  • Exagen Inc.

Recent Developments in the Market:

  • In order to create personalised nutrition for healthcare providers and their subjects using a high-end technology interface, Panaceutics Nutrition and Viocare announced a collaborative agreement in January 2022. This agreement will combine Viocare's nutrition assessment software with personalised nutrition supplementation to create an end-to-end service platform.
  • Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany joined up in February 2022 to apply precision medicine in healthcare in strategic, structural, and content-specific ways.

Global Personalized Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Personalized Medicine Diagnostics
  • Personalized Medicine Therapeutics
  • Personalized Medical Care
  • Personalized Nutrition & Wellness

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Personalized Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Personalized Medicine Market, by Product, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Personalized Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Personalized Medicine Market Dynamics

  • 3.1. Personalized Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of rare disease
      • 3.1.1.2. Growing number of clinical trials
      • 3.1.1.3. Rising demand for novel drug discovery
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Personalized Medicine
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising initiatives by key market players

Chapter 4. Global Personalized Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Personalized Medicine Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Personalized Medicine Market by Product, Performance - Potential Analysis
  • 6.3. Global Personalized Medicine Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Personalized Medicine Market, Sub Segment Analysis
    • 6.4.1. Personalized Medicine Diagnostics
    • 6.4.2. Personalized Medicine Therapeutics
    • 6.4.3. Personalized Medical Care
    • 6.4.4. Personalized Nutrition & Wellness

Chapter 7. Global Personalized Medicine Market, Regional Analysis

  • 7.1. Personalized Medicine Market, Regional Market Snapshot
  • 7.2. North America Personalized Medicine Market
    • 7.2.1. U.S. Personalized Medicine Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Personalized Medicine Market
  • 7.3. Europe Personalized Medicine Market Snapshot
    • 7.3.1. U.K. Personalized Medicine Market
    • 7.3.2. Germany Personalized Medicine Market
    • 7.3.3. France Personalized Medicine Market
    • 7.3.4. Spain Personalized Medicine Market
    • 7.3.5. Italy Personalized Medicine Market
    • 7.3.6. Rest of Europe Personalized Medicine Market
  • 7.4. Asia-Pacific Personalized Medicine Market Snapshot
    • 7.4.1. China Personalized Medicine Market
    • 7.4.2. India Personalized Medicine Market
    • 7.4.3. Japan Personalized Medicine Market
    • 7.4.4. Australia Personalized Medicine Market
    • 7.4.5. South Korea Personalized Medicine Market
    • 7.4.6. Rest of Asia Pacific Personalized Medicine Market
  • 7.5. Latin America Personalized Medicine Market Snapshot
    • 7.5.1. Brazil Personalized Medicine Market
    • 7.5.2. Mexico Personalized Medicine Market
  • 7.6. Rest of The World Personalized Medicine Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. GE Healthcare
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Illumina, Inc.
    • 8.2.3. ASURAGEN, INC.
    • 8.2.4. Abbott
    • 8.2.5. Dako A/S
    • 8.2.6. Exact Sciences Corporation
    • 8.2.7. Danaher Corporation (Cepheid, Inc.)
    • 8.2.8. Decode Genetics, Inc.
    • 8.2.9. QIAGEN
    • 8.2.10. Exagen Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Personalized Medicine Market, report scope
  • TABLE 2. Global Personalized Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Personalized Medicine Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Personalized Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Personalized Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Personalized Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Personalized Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Personalized Medicine Market
  • TABLE 69. List of primary sources, used in the study of global Personalized Medicine Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Personalized Medicine Market, research methodology
  • FIG 2. Global Personalized Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Personalized Medicine Market, key trends 2021
  • FIG 5. Global Personalized Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Personalized Medicine Market, porters 5 force model
  • FIG 7. Global Personalized Medicine Market, pest analysis
  • FIG 8. Global Personalized Medicine Market, value chain analysis
  • FIG 9. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Personalized Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Personalized Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Personalized Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Personalized Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable